365 related articles for article (PubMed ID: 31903135)
1. ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells.
Pan T; Liu J; Xu S; Yu Q; Wang H; Sun H; Wu J; Zhu Y; Zhou J; Zhu Y
Theranostics; 2020; 10(2):516-536. PubMed ID: 31903135
[No Abstract] [Full Text] [Related]
2. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
3. JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy.
Tan J; Wang HL; Yang J; Liu QQ; Li CM; Wang YQ; Fu LN; Gao QY; Chen YX; Fang JY
Theranostics; 2020; 10(13):5763-5777. PubMed ID: 32483417
[No Abstract] [Full Text] [Related]
4. ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1.
Yin J; Fu W; Dai L; Jiang Z; Liao H; Chen W; Pan L; Zhao J
Sci Rep; 2017 Jun; 7(1):4430. PubMed ID: 28667340
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated NRIP2 in colorectal cancer initiating cells modulates the Wnt pathway by targeting RORβ.
Wen Z; Pan T; Yang S; Liu J; Tao H; Zhao Y; Xu D; Shao W; Wu J; Liu X; Wang Y; Mao J; Zhu Y
Mol Cancer; 2017 Jan; 16(1):20. PubMed ID: 28137278
[TBL] [Abstract][Full Text] [Related]
7. ANKRD22 Drives Rapid Proliferation of Lgr5
Liu J; Wu J; Wang R; Zhong D; Qiu Y; Wang H; Song Z; Zhu Y
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1433-1455. PubMed ID: 34217895
[TBL] [Abstract][Full Text] [Related]
8. MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
Luraghi P; Reato G; Cipriano E; Sassi F; Orzan F; Bigatto V; De Bacco F; Menietti E; Han M; Rideout WM; Perera T; Bertotti A; Trusolino L; Comoglio PM; Boccaccio C
Cancer Res; 2014 Mar; 74(6):1857-69. PubMed ID: 24448239
[TBL] [Abstract][Full Text] [Related]
9. Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.
Sun S; Liu J; Zhao M; Han Y; Chen P; Mo Q; Wang B; Chen G; Fang Y; Tian Y; Zhou J; Ma D; Gao Q; Wu P
Cell Death Dis; 2017 Jun; 8(6):e2870. PubMed ID: 28594398
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
Zhai H; Fesler A; Ba Y; Wu S; Ju J
Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
Nenkov M; Ma Y; Gaßler N; Chen Y
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
[TBL] [Abstract][Full Text] [Related]
13. Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species-induced autophagy.
Che N; Yang Z; Liu X; Li M; Feng Y; Zhang C; Li C; Cui Y; Xuan Y
J Cell Mol Med; 2021 Feb; 25(4):2110-2120. PubMed ID: 33314691
[TBL] [Abstract][Full Text] [Related]
14. Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial protein translocase TIM44.
Huang Y; Zhou J; Luo S; Wang Y; He J; Luo P; Chen Z; Liu T; Tan X; Ou J; Miao H; Liang H; Shi C
Gut; 2018 Feb; 67(2):307-319. PubMed ID: 27849558
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.
Yu H; Zhang H; Dong M; Wu Z; Shen Z; Xie Y; Kong Z; Dai X; Xu B
Int J Oncol; 2017 Jan; 50(1):161-172. PubMed ID: 27922662
[TBL] [Abstract][Full Text] [Related]
16. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis.
Kuo CL; Chou HY; Chiu YC; Cheng AN; Fan CC; Chang YN; Chen CH; Jiang SS; Chen NJ; Lee AY
Cancer Lett; 2020 Apr; 474():138-150. PubMed ID: 31987921
[TBL] [Abstract][Full Text] [Related]
18. CQ synergistically sensitizes human colorectal cancer cells to SN-38/CPT-11 through lysosomal and mitochondrial apoptotic pathway via p53-ROS cross-talk.
Chen P; Luo X; Nie P; Wu B; Xu W; Shi X; Chang H; Li B; Yu X; Zou Z
Free Radic Biol Med; 2017 Mar; 104():280-297. PubMed ID: 28131902
[TBL] [Abstract][Full Text] [Related]
19. The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model.
Margolin DA; Myers T; Zhang X; Bertoni DM; Reuter BA; Obokhare I; Borgovan T; Grimes C; Green H; Driscoll T; Lee CG; Davis NK; Li L
FASEB J; 2015 Aug; 29(8):3571-81. PubMed ID: 25962655
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction induces radioresistance in colorectal cancer by activating [Ca
Shi Y; Wang Y; Jiang H; Sun X; Xu H; Wei X; Wei Y; Xiao G; Song Z; Zhou F
Cell Death Dis; 2021 Sep; 12(9):837. PubMed ID: 34489398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
